Wockhardt Of India Said Eyeing MNCs To Share Biosimilar Work
This article was originally published in PharmAsia News
Executive Summary
India's Wockhardt is in the market for a multinational partner for its biosimilar business. The company is said to be negotiating with MNCs such as Eli Lilly, Pfizer, Sandoz and Sanofi-Aventis. Wockhardt is willing to sell a half-interest share in its biosimilar division, according to one source, even though that would mean spinning it off into a separate company. Such a merger, however, would not be expected to be completed for another year. (Click here for more